论文部分内容阅读
验证 BPQ- 型血液净化量子治疗仪 (BPQ- )治疗急性脑梗死疗效及安全性。方法 :92例急性脑梗死患者随机分为两组 ,其中一组采用常规治疗 ,另一组在常规治疗基础上于入院后 1天、4天、7天、10天加用 BPQ- 。于入院 14天后进行疗效评定 ,并检测治疗前后血液流变学指标。结果 :BPQ- 治疗急性脑梗死疗效高于对照组 (P<0 .0 5 )。进行亚型分析发现 ,BPQ- 对病情分型为中型和发病 3天内开始治疗的脑梗死患者疗效更为明显。经治疗后全血粘度、红细胞聚集指数均明显下降。结论 :BPQ- 能够降低血粘度 ,治疗急性脑梗死疗效高 ,副作用少。
To verify the efficacy and safety of BPQ-BPQ-1 in the treatment of acute cerebral infarction. Methods: Ninety-two patients with acute cerebral infarction were randomly divided into two groups. One group received routine treatment and the other group received BPQ-1 on day 1, 4, 7 and 10 after admission. Efficacy was assessed 14 days after admission and blood rheology was measured before and after treatment. Results: The therapeutic effect of BPQ-treated acute cerebral infarction was higher than that of the control group (P <0.05). Subtype analysis found that BPQ-treated patients with cerebral infarction were more likely to be classified as moderately diagnosed and treated within 3 days of onset. After treatment, the whole blood viscosity, erythrocyte aggregation index were significantly decreased. Conclusion: BPQ - can reduce blood viscosity, the treatment of acute cerebral infarction with high efficacy, fewer side effects.